Skip to main content
CivicGate

HR 7980
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Protecting Americans from Unsafe Drugs Act of 2026

To amend the Federal Food, Drug, and Cosmetic Act to expand certain authorities with respect to the recall of controlled substances to apply with respect to all drugs, and for other purposes.

Introduced Mar 18, 2026

Latest action (Mar 18, 2026) Referred to the House Committee on Energy and Commerce.

Policy area
Issues
Healthcare

Summary

  • Expands FDA's existing authority to order a stop to distribution and a recall of a drug, which currently applies to controlled substances, so that it applies to all drugs.
  • Allows the FDA Director of the Center for Biologics Evaluation and Research, in addition to the existing director, to take part in the section's order process.
  • Extends the import and export restriction in section 801(a) of the Act from controlled substances to all drugs subject to a distribution-stop order.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)

Money behind the sponsor

Top reported contributors to Maxine Dexter’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.

  • OHSU $11,575
  • NORTHWEST PERMANENTE $10,758
  • HOWARD PROPERTIES $9,900
  • Employer not reported $9,650
  • STATE OF OREGON $7,925

Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Maxine Dexter → · Outside spending →

Actions (2)

  1. Mar 18, 2026 Referred to the House Committee on Energy and Commerce. · house
  2. Mar 18, 2026 Introduced in House

Full text

IN THE HOUSE OF REPRESENTATIVES

March 18, 2026

Ms. Dexter introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to expand certain authorities with respect to the recall of controlled substances to apply with respect to all drugs, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Protecting Americans from Unsafe Drugs Act of 2026”.

SEC. 2. NOTIFICATION, NONDISTRIBUTION, AND RECALL OF DRUGS.

(a) Order To Cease Distribution and Recall.—Section 569D of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb-8d) is amended—

(1) in the section heading, by striking “controlled substances” and inserting “drugs”;

(2) by striking “controlled substance” each place such term appears and inserting “drug”;

(3) in subsection (b)—

(A) by striking “controlled substances” and inserting “drugs”; and

(B) by inserting “of subsection (a)” after “an order pursuant to paragraph (1) or an amended order pursuant to subparagraph (B) or (C) of paragraph (3)”; and

(4) in subsection (c), by striking “or an official senior to such Director” and inserting “or the Director of the Center for Biologics Evaluation and Research (or an official senior to either such Director)”.

(b) Imports and Exports.—Section 801(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381(a)) is amended by striking “is a controlled substance subject to an order under section 569D” and inserting “is a drug subject to an order under section 569D”. <all>

Text versions (1)

  • Introduced in House · Mar 18, 2026

Only one text version is on file, so there’s no earlier version to compare against yet.

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

Comments

Comments

Loading comments…